New antibiotic susceptibility testing definitions: "I" no longer means intermediate susceptibility
dc.contributor.author | Aguilera-Alonso, David | |
dc.contributor.author | Martinez Campos, Leticia | |
dc.contributor.author | Fernandez Llamazares, Cecilia M. | |
dc.contributor.author | Calvo, Cristina | |
dc.contributor.author | Baquero-Artigao, Fernando | |
dc.contributor.author | Grp Trabajo PROA SEIP | |
dc.contributor.authoraffiliation | [Aguilera-Alonso, David] Hosp Gen Univ Gregorio Maranon, Sociedad Espanola Infectol Pediat SEIP, Red Invest Traslac Infectol Pediat RITIP, Secc Enfermedades Infecc,Serv Pediat,Inst Invest, Madrid, Spain | |
dc.contributor.authoraffiliation | [Martinez Campos, Leticia] Hosp Torrecardenas, Sociedad Espanola Infectol Pediat SEIP, Serv Pediat, Almeria, Spain | |
dc.contributor.authoraffiliation | [Fernandez Llamazares, Cecilia M.] Hosp Gen Univ Gregorio Maranon, Sociedad Espanola Farmacia Hosp SEFH, Serv Farm, Madrid, Spain | |
dc.contributor.authoraffiliation | [Calvo, Cristina] Hosp La Paz, Sociedad Espanola Infectola Pediat SEIP, Serv Pediat Enfermedades Infecc & Patol Trop, Red Invest Traslac Infectol Pediat RITIP, Madrid, Spain | |
dc.contributor.authoraffiliation | [Baquero-Artigao, Fernando] Hosp La Paz, Sociedad Espanola Infectola Pediat SEIP, Serv Pediat Enfermedades Infecc & Patol Trop, Red Invest Traslac Infectol Pediat RITIP, Madrid, Spain | |
dc.date.accessioned | 2025-01-07T12:44:50Z | |
dc.date.available | 2025-01-07T12:44:50Z | |
dc.date.issued | 2022-02-01 | |
dc.identifier.doi | 10.1016/j.anpedi.2021.04.013 | |
dc.identifier.essn | 1695-9531 | |
dc.identifier.issn | 1695-4033 | |
dc.identifier.pmid | 34074616 | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.anpedi.2021.04.013 | |
dc.identifier.uri | https://hdl.handle.net/10668/24899 | |
dc.identifier.wosID | 751760800012 | |
dc.issue.number | 2 | |
dc.journal.title | Anales de pediatria | |
dc.journal.titleabbreviation | An. pediatr. | |
dc.language.iso | es | |
dc.organization | SAS - Hospital Universitario Torrecárdenas | |
dc.page.number | 157-+ | |
dc.publisher | Ediciones doyma s a | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Sense eucast breakpoints | |
dc.subject | Guidelines | |
dc.subject | Therapy | |
dc.subject | Name | |
dc.title | New antibiotic susceptibility testing definitions: "I" no longer means intermediate susceptibility | |
dc.type | letter | |
dc.type.hasVersion | VoR | |
dc.volume.number | 96 | |
dc.wostype | Letter |